Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

Outcome of prostate cancer patients with initial PSA> or =20 ng/ml undergoing radical prostatectomy.

Zwergel U, Suttmann H, Schroeder T, Siemer S, Wullich B, Kamradt J, Lehmann J, Stoeckle M.

Eur Urol. 2007 Oct;52(4):1058-65. Epub 2007 Mar 28.

PMID:
17418938
2.
3.
4.

The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy.

Ward JF, Blute ML, Slezak J, Bergstralh EJ, Zincke H.

J Urol. 2003 Nov;170(5):1872-6.

PMID:
14532796
5.
6.

Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.

Steuber T, BudÀus L, Walz J, Zorn KC, Schlomm T, Chun F, Ahyai S, Fisch M, Sauter G, Huland H, Graefen M, Haese A.

BJU Int. 2011 Jun;107(11):1755-61. doi: 10.1111/j.1464-410X.2010.09730.x. Epub 2010 Oct 13.

7.

Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy.

Bianco FJ Jr, Scardino PT, Stephenson AJ, Diblasio CJ, Fearn PA, Eastham JA.

Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):448-53.

PMID:
15890586
8.

The role of radical prostatectomy in patients with clinically localized prostate cancer and a prostate-specific antigen level >20 ng/ml.

Bastide C, Kuefer R, Loeffler M, de Petriconi R, Gschwend J, Hautmann R.

Prostate Cancer Prostatic Dis. 2006;9(3):239-44. Epub 2006 Jul 11.

PMID:
16832384
10.

A retrospective analysis of the results of p(65) + Be neutrontherapy for the treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Neuve. Part I: Survival and progression-free survival.

Scalliet PG, Remouchamps V, Lhoas F, Van Glabbeke M, Curran D, Ledent T, Wambersie A, Richard F, Van Cangh P.

Cancer Radiother. 2001 Jun;5(3):262-72.

PMID:
11446080
11.

The role of radical prostatectomy in patients with pretreatment prostate-specific antigen > or = 40 ng/mL.

Vanasupa BP, Paquette EL, Wu H, Sun L, McLeod DG, Moul JW.

Urol Oncol. 2002 Jul-Aug;7(4):167-72.

PMID:
12474533
12.

Local control and long-term disease-free survival for stage D1 (T2-T4N1-N2M0) prostate cancer after radical prostatectomy in the PSA era.

Gjertson CK, Asher KP, Sclar JD, Goluboff ET, Olsson CA, Benson MC, McKiernan JM.

Urology. 2007 Oct;70(4):723-7.

PMID:
17991544
13.

Oncologic outcome after radical prostatectomy in men with PSA values above 20 ng/ml: a monocentric experience.

Nguyen K, Eltz S, Drouin SJ, Comperat E, Audenet F, Renard-Penna R, Bitker MO, Chartier-Kastler E, Richard F, Cussenot O, RouprĂȘt M.

World J Urol. 2009 Oct;27(5):653-8. doi: 10.1007/s00345-009-0419-8. Epub 2009 May 23.

PMID:
19466429
14.

Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database.

King CR, Freedland SJ, Terris MK, Kane CJ, Amling CL, Aronson WJ, Presti JC Jr.

Urology. 2007 May;69(5):921-6.

PMID:
17482935
15.

Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.

Paparel P, Cronin AM, Savage C, Scardino PT, Eastham JA.

Eur Urol. 2009 Feb;55(2):404-10. doi: 10.1016/j.eururo.2008.07.007. Epub 2008 Jul 14.

PMID:
18639970
16.

The outcome of patients with pathological Gleason score >or=8 prostate cancer after radical prostatectomy.

Rodriguez-Covarrubias F, Larre S, De La Taille A, Abbou CC, Salomon L.

BJU Int. 2008 Feb;101(3):305-7. Epub 2007 Oct 17.

17.

After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.

Sengupta S, Blute ML, Bagniewski SM, Inman B, Leibovich BC, Slezak JM, Myers RP, Zincke H.

BJU Int. 2008 Jan;101(2):170-4. doi: 10.1111/j.1464-410X.2007.07270.x.

18.

Positive surgical margins after radical prostatectomy: do they have an impact on biochemical or clinical progression?

Pfitzenmaier J, Pahernik S, Tremmel T, Haferkamp A, Buse S, Hohenfellner M.

BJU Int. 2008 Nov;102(10):1413-8. doi: 10.1111/j.1464-410X.2008.07791.x. Epub 2008 Jun 4.

19.
20.

Prognostic value of surgical margin status for biochemical recurrence following radical prostatectomy.

Hashimoto K, Masumori N, Takei F, Fukuta F, Takahashi A, Itoh N, Hasegawa T, Tsukamoto T.

Jpn J Clin Oncol. 2008 Jan;38(1):31-5. doi: 10.1093/jjco/hym135. Epub 2008 Jan 17.

PMID:
18203710

Supplemental Content

Support Center